Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting

J Mater Sci Mater Med. 2009 Jan;20(1):301-7. doi: 10.1007/s10856-008-3577-0. Epub 2008 Sep 13.

Abstract

By loading doxorubicin (DOX) on 5-carboxyl-fluorescein (FAM) labeled AGKGTPSLETTP peptide (A54) coupled starch-coated iron oxide nanoparticles (SIONs), we prepared a novel aqueous drug delivery system with both magnetic and biomolecular targeting, which was specific to human hepatocellular carcinoma cell line BEL-7402. The saturated extent of adsorption reached 2.0 mg DOX/mg A54-SIONs at 28 degrees C, which provided a rather high dose of DOX loading for application. Tests in vitro demonstrated the specificity of DOX-loaded A54-SIONs to BEL-7402 cells. The microscopy images proved that DOX-loaded A54-SIONs were successfully targeted to tumor tissue of nude mice with an external magnetic field in vivo. MTT assay showed higher cytostatic effect of DOX-loaded A54-SIONs to hepatocellular carcinoma cells BEL-7402 than that of DOX-loaded SIONs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / isolation & purification
  • Cell Line, Tumor
  • Doxorubicin / administration & dosage
  • Drug Carriers / chemistry
  • Drug Carriers / isolation & purification*
  • Drug Delivery Systems*
  • Fluoresceins
  • Fluorescent Dyes
  • Humans
  • Liver Neoplasms, Experimental / drug therapy
  • Liver Neoplasms, Experimental / pathology
  • Magnetics
  • Materials Testing
  • Metal Nanoparticles / chemistry
  • Mice
  • Mice, Nude
  • Microscopy, Fluorescence
  • Neoplasm Transplantation
  • Oligopeptides / chemistry
  • Spectroscopy, Fourier Transform Infrared
  • Transplantation, Heterologous

Substances

  • Antibiotics, Antineoplastic
  • Biocompatible Materials
  • Drug Carriers
  • Fluoresceins
  • Fluorescent Dyes
  • Oligopeptides
  • 4-carboxyfluorescein
  • Doxorubicin